Medically Supervised Peptide Care

Human Growth Hormone Peptide Therapy Personalized Evaluation and Clinical Guidance

Name: Alpha Hormones Inc.
Price range: $$$

Explore medically supervised peptide options that may support appropriate hormone-related health goals. Care begins with a provider evaluation and is based on your medical history, laboratory findings, eligibility, and ongoing monitoring.

Provider evaluation
Individualized care planning
Ongoing clinical monitoring

Schedule a Consultation

Growth Hormone Education

What Is HGH Peptide Therapy?

HGH peptide therapy refers to the clinical use of peptides—short chains of amino acids—that interact with specific receptors in the body. Certain peptides act as growth hormone secretagogues, signaling the pituitary gland to release the body’s own growth hormone rather than supplying recombinant human growth hormone directly.

Growth hormone contributes to normal metabolism, tissue maintenance, body composition, and physiological regulation. Its secretion changes with age, sleep, nutrition, body composition, illness, and other health factors. Symptoms alone cannot diagnose adult growth hormone deficiency; clinical evaluation and appropriate testing are required.

Recombinant human growth hormone is tightly regulated and approved only for specific medical conditions. Alpha Hormones® does not prescribe HGH for unapproved anti-aging or general wellness use. When clinically and legally appropriate, patients may be evaluated for an FDA-approved therapy or another peptide-related option within applicable standards.

Important distinction: Growth hormone–releasing peptides are not HGH. Their indications, evidence, regulatory status, expected effects, and risks differ by medication.

Educational graphic showing growth hormone levels changing with age

Clinical Evaluation

Symptoms That May Warrant Evaluation

These concerns are common and may have many causes. They do not establish growth hormone deficiency on their own.

Reduced muscle mass or strength
Lower exercise capacity
Slower recovery
Low energy
Changes in body composition
Reduced bone density
Sleep concerns
Changes in cognitive or emotional well-being

Therapy Overview

Peptides That Affect Growth Hormone Signaling

The medications below have different regulatory histories and should not be presented as interchangeable anti-aging treatments.

Diagram of the hypothalamic, pituitary, growth hormone, and IGF-1 signaling pathway

Clinical and regulatory review required

Sermorelin

Sermorelin is a synthetic analog of the first 29 amino acids of growth hormone–releasing hormone. It stimulates pituitary growth hormone release through normal signaling pathways and produces a pulsatile response rather than supplying HGH directly.

A sermorelin product was historically FDA-approved for diagnostic use in children and was later discontinued. Current compounded sermorelin preparations are not FDA-approved. Evidence for broader wellness applications is still developing, so treatment decisions are made individually after reviewing clinical goals, available research, and applicable standards.

FDA-approved for one specific indication

Tesamorelin

Tesamorelin is a growth hormone–releasing factor analog that stimulates pituitary growth hormone secretion and increases IGF-1. It is FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.

Its established FDA-approved use is specific and it is not labeled as a general weight-management medication. Any consideration outside the approved indication requires a sound clinical rationale, an informed discussion of the available evidence, and appropriate monitoring.

Potential Benefits

What Patients May Hope to Improve

When a therapy is clinically appropriate, some patients may notice improvements in areas influenced by growth hormone signaling. Response varies by diagnosis, medication, baseline health, sleep, nutrition, activity, and treatment duration.

Educational infographic describing body systems influenced by growth hormone

Body Composition

Selected patients may experience favorable changes in visceral fat or lean body mass, depending on the medication and indication.

Recovery and Exercise

Some patients report changes in recovery, exercise tolerance, or physical well-being when an underlying deficiency or appropriate indication is addressed.

Sleep Quality

Sleep may improve for some patients, although sleep apnea and other common causes of poor sleep should also be evaluated.

Energy and Mental Clarity

Energy, focus, motivation, and overall quality of life may change over time, but these concerns are influenced by many health and lifestyle factors.

Bone, Skin, and Tissue Health

Growth hormone pathways contribute to bone and tissue metabolism; meaningful changes generally require time and should be assessed clinically.

Metabolic Measures

Certain therapies may affect waist measurement, IGF-1, or other metabolic markers, which should be interpreted alongside glucose and cardiovascular health.

Realistic expectations: These are potential areas of response, not guaranteed outcomes or a fixed timeline. The expected benefit depends on the specific treatment and why it is being prescribed.

A List of Gradual Improvements Some Patients May Experience With HGH Peptide Therapy

Month 1: Establishing a Baseline

Track sleep quality and energy
Review injection technique and adherence
Monitor early tolerability
Record recovery and activity levels

Month 2: Early Response

Compare sleep and recovery with baseline
Review energy and exercise tolerance
Assess swelling, joint symptoms, or headaches
Adjust the plan when clinically indicated

Month 3: Clinical Review

Reassess symptoms and quality of life
Review IGF-1 or metabolic testing when relevant
Compare strength and body measurements
Confirm that benefits justify continued treatment

Month 4: Trend Assessment

Evaluate whether progress is sustained
Review recovery and physical function
Discuss plateaus or changing goals
Continue monitoring tolerability

Month 5: Longer-Term Changes

Review waist or body-composition trends
Assess skin, sleep, and general well-being
Reinforce nutrition, activity, and recovery
Review laboratory trends when appropriate

Month 6: Continue or Refine

Complete a broader benefit-risk review
Confirm that treatment goals remain meaningful
Modify dose or strategy when appropriate
Plan the next monitoring interval

The order and timing of changes vary considerably. Some patients may notice no meaningful improvement, and claims involving eyesight, immunity, hair regrowth, wound healing, cellulite removal, or disappearance of pain are not presented as expected treatment outcomes.

What to Expect

A Clinically Guided Evaluation Process

There is no reliable week-by-week timeline that applies to every patient. Care begins with determining whether treatment is indicated and safe.

Medical Review

Discuss symptoms, diagnoses, medications, sleep, nutrition, exercise, and treatment goals.

Appropriate Testing

Obtain targeted laboratory evaluation when clinically indicated; random growth hormone levels alone are not diagnostic.

Shared Decision

Review the evidence, regulatory status, alternatives, potential risks, cost, and realistic expectations.

Ongoing Monitoring

Reassess symptoms, IGF-1 when relevant, glucose control, side effects, and whether continued therapy remains appropriate.

Measured Over Time

How Response Is Assessed

If therapy is appropriate, response is evaluated over time rather than promised on a fixed schedule. The goal is meaningful clinical improvement without pushing laboratory values beyond an appropriate range.

SymptomsEnergy, sleep, recovery, and quality-of-life concerns are reassessed using the same baseline measures.

Body compositionChanges in waist measurement, lean mass, or other relevant measures are interpreted alongside nutrition and activity.

Laboratory markersIGF-1 and metabolic markers may be followed when relevant to the medication and indication.

TolerabilitySwelling, joint symptoms, numbness, headaches, glucose changes, and other concerns are reviewed promptly.

Safety and Monitoring

Thoughtful Care and Follow-Up

Growth hormone signaling influences several tissues and metabolic pathways. A measured approach helps match treatment to a meaningful clinical goal while keeping hormone levels and overall health in view.

Review medical history, pituitary health, pregnancy status, and factors that may influence treatment selection.
Monitor glucose control, fluid retention, joint symptoms, nerve symptoms, and sleep quality when relevant.
Use only medications obtained through lawful, appropriately regulated channels.
Set realistic goals for body composition, recovery, energy, and other patient priorities.
Adjust the plan when the response, laboratory findings, or tolerability indicate that a change would be helpful.

Patient discussing peptide therapy and health goals with a medical provider

Your Next Step

Is Peptide Therapy Right for You?

Meet with our medical team to review your symptoms, health history, treatment goals, and appropriate testing before deciding whether a clinically and legally available option fits your needs.

Book an Appointment

This content is for general education and does not replace medical advice, diagnosis, or treatment. Peptide products differ in approval status, evidence, quality, and legal availability. Treatment eligibility, risks, benefits, and results vary. No outcome is guaranteed.

Our Mission

Helping patients understand and optimize their health through personalized, evidence-based medicine focused on hormone health, longevity, and lasting well-being.